Is a D-dimer level of 216 ng/mL (FEU or DDU) considered normal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is a D-dimer of 216 ng/mL Normal?

Yes, a D-dimer level of 216 ng/mL is normal and effectively rules out acute venous thromboembolism (VTE) in patients with low or intermediate clinical probability of pulmonary embolism (PE) or deep vein thrombosis (DVT).

Understanding the Normal Range

The standard D-dimer cutoff for excluding acute VTE is <500 ng/mL (FEU) 1, 2. Your value of 216 ng/mL falls well below this threshold, placing it clearly in the normal range. This assumes the result is reported in fibrinogen equivalent units (FEU), which is the most common reporting standard 3.

Clinical Significance by Risk Category

For Low or Intermediate Risk Patients

  • A normal D-dimer (<500 ng/mL) has a negative predictive value exceeding 99% for PE 1
  • No imaging studies are indicated when D-dimer is normal in these patients 1, 4
  • The sensitivity of D-dimer testing for acute VTE exceeds 95% in most validated studies 5, 2

Age-Adjusted Considerations

If you are over 50 years old, the age-adjusted threshold would be even more favorable:

  • Age-adjusted cutoff = age × 10 ng/mL 1, 2
  • For example, at age 60: cutoff would be 600 ng/mL
  • At age 70: cutoff would be 700 ng/mL
  • Your value of 216 ng/mL remains well below any age-adjusted threshold

Important Caveats

This interpretation assumes:

  1. Appropriate clinical context: D-dimer should only be used in patients with LOW or INTERMEDIATE pretest probability of VTE 1, 2. If clinical suspicion is HIGH, imaging should be performed regardless of D-dimer level 1.

  2. Correct assay type: This assumes a highly sensitive D-dimer assay (ELISA-based) was used 1. Older latex agglutination assays have lower sensitivity and should only be used in low-risk patients 1.

  3. Correct units: Confirm your result is in ng/mL FEU, not D-dimer units (DDU). FEU values are approximately 2-fold higher than DDU 3. If your result is in DDU, multiply by 2 to get FEU equivalent (216 DDU = 432 FEU, still normal).

  4. Timing matters: D-dimer should be measured when acute thrombosis is suspected. The test has limited utility for:

    • Recurrent VTE (may remain elevated from prior events)
    • Patients already on anticoagulation 6
    • Chronic conditions where D-dimer is persistently elevated

When D-dimer Alone Is Not Sufficient

Do not rely on D-dimer alone if:

  • High clinical probability of PE/DVT exists (proceed directly to imaging) 1, 2
  • Patient has active cancer, recent surgery, or severe inflammatory conditions (D-dimer specificity is reduced) 2, 3
  • Symptoms have been present >7-10 days (sensitivity may decrease)
  • Patient is hospitalized with critical illness (baseline D-dimer often elevated) 6

Special Populations

COVID-19 Context

If this D-dimer was checked in the context of COVID-19, note that:

  • D-dimer >5000 ng/mL (5 mg/mL) in COVID-19 patients indicates very high thrombotic risk 6
  • Your value of 216 ng/mL suggests low thrombotic risk in this context
  • However, D-dimer in COVID-19 also reflects disease severity and lung injury, not just thrombosis 6

Vaccine-Induced Thrombotic Thrombocytopenia (VITT)

For the rare condition of VITT after COVID-19 vaccination:

  • Diagnostic threshold is D-dimer >4000 μg/mL (4000 ng/mL FEU) 7
  • Your value of 216 ng/mL makes VITT extremely unlikely
  • VITT also requires thrombocytopenia and occurs 5-30 days post-vaccination 7

Bottom Line

Your D-dimer of 216 ng/mL is definitively normal and, when combined with low or intermediate clinical probability, safely excludes acute PE or DVT without need for imaging 1, 2, 4. This assumes proper clinical risk stratification was performed and a validated, highly sensitive assay was used.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.